| Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients (NCT05771181) | Fudan University | 2023-03-01 |
| Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C) (NCT05732493) | Fudan University | 2023-03-01 |
| Pulmonary Ventilation Function Between Patients With Primary and Recurrent Incisional Hernia: a Cross-sectional Study (NCT05991024) | Fudan University | 2023-03-01 |
| A Retrospective Analysis of Incisional Hernia Repair's Postoperative Recurrence (NCT06102551) | Fudan University | 2023-03-01 |
| Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy (NCT05703581) | Fudan University | 2023-03-01 |
| Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma (NCT05759312) | Fudan University | 2023-03-01 |
| Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma (NCT05675462) | Fudan University | 2023-03-01 |
| The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer. (NCT05732129) | Fudan University | 2023-03-01 |
| A Study of IO Plus Radiotherapy in Patients With Advanced ESCC. (NCT05760391) | Fudan University | 2023-02-28 |
| Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors (NCT05847855) | Fudan University | 2023-02-27 |
| Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004) (NCT05281003) | Fudan University | 2023-02-20 |
| Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) (NCT05717803) | Fudan University | 2023-02-15 |
| Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer (NCT05982301) | Fudan University | 2023-02-09 |
| Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer (NCT05759572) | Fudan University | 2023-02-01 |
| PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer (NCT05759546) | Fudan University | 2023-02-01 |
| Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL) (NCT06170216) | Fudan University | 2023-01-10 |
| a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy (NCT05670691) | Fudan University | 2023-01-10 |
| Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies. (NCT05673824) | Fudan University | 2023-01-03 |
| Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma (NCT06344299) | Fudan University | 2023-01-01 |
| Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer (NCT05975749) | Fudan University | 2023-01-01 |
| Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer (NCT05645094) | Fudan University | 2023-01-01 |
| Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer (NCT05840341) | Fudan University | 2023-01-01 |
| Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer (NCT06121700) | Fudan University | 2023-01-01 |
| Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma (NCT05638984) | Fudan University | 2023-01-01 |
| SNF Platform Study of HR+/ HER2-advanced Breast Cancer (NCT05594095) | Fudan University | 2022-12-30 |
| Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma (NCT05587543) | Fudan University | 2022-12-28 |
| The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer (NCT05555888) | Fudan University | 2022-12-12 |
| Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy (NCT05643417) | Fudan University | 2022-12-01 |
| A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis (NCT05359393) | Fudan University | 2022-12-01 |
| Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary Tumor (NCT05797987) | Fudan University | 2022-12-01 |
| The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer (NCT05634590) | Fudan University | 2022-12-01 |
| The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer (NCT05628038) | Fudan University | 2022-11-30 |
| A Longitudinal Study of the Trajectory of Financial Toxicity and Its Relationship With Symptom Burden in Breast Cancer Patients (NCT05964816) | Fudan University | 2022-11-16 |
| Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial (NCT05326932) | Fudan University | 2022-11-03 |
| Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy (NCT05582499) | Fudan University | 2022-11-01 |
| Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower) (NCT05577923) | Fudan University | 2022-11-01 |
| Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic Breast Cancer Patients (NCT05839288) | Fudan University | 2022-11-01 |
| Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin (NCT06030934) | Fudan University | 2022-10-24 |
| Acute Health Effects of High Temperature Exposure (NCT05575752) | Fudan University | 2022-10-23 |
| GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma (NCT05668884) | Fudan University | 2022-10-18 |
| Multi-mode Ablation and Molecular Imaging Multi-omics Study for Digestive-Origin Malignant Liver Tumors (NCT06588569) | Fudan University | 2022-10-12 |
| GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer (NCT05575804) | Fudan University | 2022-10-01 |
| Laparoscopic vs Open Total Gastrectomy for Gastric Cancer (NCT05537129) | Fudan University | 2022-10-01 |
| Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor (NCT06190782) | Fudan University | 2022-09-27 |
| Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer (NCT05541783) | Fudan University | 2022-09-15 |
| Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer (NCT05531123) | Fudan University | 2022-09-10 |
| Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients (NCT05174832) | Fudan University | 2022-09-07 |
| Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer (NCT05574881) | Fudan University | 2022-09-01 |
| The Rechallenge of ADCs in MBC Patients (NCT05571618) | Fudan University | 2022-09-01 |
| The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma (NCT05774275) | Fudan University | 2022-08-25 |
| Evaluation of a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA to the Community Colorectal Cancer Screening Program (NCT05638243) | Fudan University | 2022-08-20 |
| Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation (NCT05489848) | Fudan University | 2022-08-20 |
| PD-1 Inhibitors With or Without Radiation in Advanced Melanoma (NCT05498805) | Fudan University | 2022-08-15 |
| Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer (NCT05602831) | Fudan University | 2022-08-10 |
| Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study (NCT05753163) | Fudan University | 2022-08-02 |
| Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP (NCT05454358) | Fudan University | 2022-08-02 |
| The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma (NCT05839275) | Fudan University | 2022-08-01 |
| PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy (NCT06156878) | Fudan University | 2022-08-01 |
| Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c) (NCT05306028) | Fudan University | 2022-08-01 |
| PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery (NCT05468138) | Fudan University | 2022-08-01 |
| Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy (NCT05442632) | Fudan University | 2022-07-25 |
| Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005) (NCT05443841) | Fudan University | 2022-07-18 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis (NCT05406466) | Fudan University | 2022-07-15 |
| MammaPrint Value for Pre-menopausal Breast Cancer Patients (NCT05474391) | Fudan University | 2022-07-15 |
| Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy (NCT05435313) | Fudan University | 2022-07-12 |
| A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer (NCT05438706) | Fudan University | 2022-07-10 |
| Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT (NCT05628922) | Fudan University | 2022-07-02 |
| The Study on the Mechanism of Radiotherapy-elicited Immune Response (NCT06393140) | Fudan University | 2022-07-01 |
| Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer (NCT05475847) | Fudan University | 2022-07-01 |
| Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy (NCT05451719) | Fudan University | 2022-07-01 |
| A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China (NCT06591039) | Fudan University | 2022-07-01 |
| Reverse Triple Negative Immune Resistant Breast Cancer (NCT05076682) | Fudan University | 2022-06-30 |
| PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC (NCT06156891) | Fudan University | 2022-06-29 |
| Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy (NCT05483543) | Fudan University | 2022-06-20 |
| Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC (NCT05386524) | Fudan University | 2022-06-15 |
| Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery (NCT05408676) | Fudan University | 2022-06-10 |
| Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer (NCT05403333) | Fudan University | 2022-06-10 |
| Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer (NCT05407155) | Fudan University | 2022-06-09 |
| HER2-positive Breast Cancer Project Initiated by Investigators (NCT05346328) | Fudan University | 2022-06-01 |
| DDP ip Combined With AG in PDAC With Peritoneal Metastasis (NCT05222204) | Fudan University | 2022-05-15 |
| Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy (NCT05303038) | Fudan University | 2022-05-01 |
| Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms (NCT05316480) | Fudan University | 2022-05-01 |
| Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites (NCT05303844) | Fudan University | 2022-04-02 |
| Real-world Study of UTD1 in Chinese Advanced Breast Cancer (NCT05386511) | Fudan University | 2022-04-01 |
| Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer (NCT05212857) | Fudan University | 2022-04-01 |
| Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point (NCT05299021) | Fudan University | 2022-04-01 |
| Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer (NCT05303090) | Fudan University | 2022-03-31 |
| Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer (NCT05247268) | Fudan University | 2022-03-11 |
| Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL (NCT05238064) | Fudan University | 2022-03-01 |
| RWE About QOL and Compliance of Patients With OFS in China (NCT05122377) | Fudan University | 2022-03-01 |
| Social Media-based Vaccine Confidence and Hesitancy Monitoring (NCT05442762) | Fudan University | 2022-03-01 |
| R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse (NCT05257018) | Fudan University | 2022-02-26 |
| Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC (NCT05254847) | Fudan University | 2022-02-24 |
| SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009) (NCT04527419) | Fudan University | 2022-02-09 |
| A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer (NCT05257122) | Fudan University | 2022-02-01 |
| Detection and Analysis of MBC With Heterogeneous ER Expression (NCT05392985) | Fudan University | 2022-01-15 |
| Efficacy and Safety of T+A+RAD in HCC (NCT05396937) | Fudan University | 2022-01-12 |
| HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection (NCT05311319) | Fudan University | 2022-01-11 |
| Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia (NCT05172999) | Fudan University | 2022-01-08 |
| ZR-CHOP in DLBCL With Specific Gene Abnormality (NCT05290337) | Fudan University | 2022-01-04 |